SCHEMBL30516667

SCHEMBL30516667

COC(=O)C1CC2(CCC2)C1NC(=O)c1ccsc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.40
▸ HPGD P15428 1/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ CES2 O00748 1/20 0.34
▸ CES1 P23141 1/20 0.34
▸ MAPK10 P53779 1/20 0.34
▸ TAS1R3 Q7RTX0 1/20 0.34
▸ TAS1R1 Q7RTX1 1/20 0.34
▸ OPRM1 P35372 1/20 0.34
▸ OPRK1 P41145 1/20 0.34
▸ PTGDR Q13258 2/20 0.33
▸ KIF11 P52732 1/20 0.33
▸ LCK P06239 1/20 0.33
▸ FYN P06241 1/20 0.33
▸ DAO P14920 1/20 0.33
▸ TBXA2R P21731 1/20 0.33
▸ KCNK3 O14649 1/20 0.33
▸ KCNK9 Q9NPC2 1/20 0.33
▸ CTSS P25774 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30516654 0.86 HDAC1 (0.43) HDAC1HPGDNPC1RAB9ACES2
SCHEMBL30516661 0.80 NPC1 (0.42) HPGDNPC1RAB9AMAPK10DAO
SCHEMBL30516656 0.78 TSHR (0.49) HDAC1HPGDNPC1RAB9ATAS1R3
SCHEMBL30516632 0.77 CNR2 (0.36) HPGDNPC1RAB9APTGDR
SCHEMBL30516651 0.74 HDAC1 (0.50) HDAC1HPGDNPC1RAB9ACES2
SCHEMBL30516637 0.72 NPC1 (0.38) NPC1RAB9A
SCHEMBL30516655 0.72 ALDH1A1 (0.31) —
SCHEMBL12181152 0.67 HDAC1 (0.55) HDAC1HPGDNPC1RAB9ACES2
SCHEMBL12181487 0.67 HDAC1 (0.55) HDAC1HPGDNPC1RAB9ACES2
SCHEMBL15296751 0.66 HDAC1 (0.58) HDAC1HPGDNPC1RAB9ACES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116529238-A Novel prostaglandin E 2 Compounds with receptor inhibiting activity and uses thereof 治纳辅医药科技有限公司 2023-08-01 — — CN disclosed
Send feedback